Evidence map›Paper›PMID 37110479›Full record

ReviewMicroorganisms2023

Dendritic Cells and

Iti Saraav, L David Sibley

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Early life infection withGut microbes · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Iti SaraavDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
L David SibleyDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Washington University in St. Louis · US

Funding

Molecular Basis of Human ToxoplasmosisR01AI118426 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2015 to 2024
$6.0M
Effect of Microbial Metabolites on Growth of CryptosporidiumR01AI145496 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2020 to 2023
$2.7M
Genetic Basis of Host Infectivity by CryptosporidiumR01AI175150 · NIAID · WASHINGTON UNIVERSITY · PI L. David Sibley · 2024 to 2026
$2.0M
Cryptosporidiosis and Oral ToleranceR21AI171858 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2023 to 2024
$428k
NIAID NIH HHS R01 AI118426NIAID NIH HHS R01 AI145496NIAID NIH HHS R01 AI175150NIAID NIH HHS R21 AI171858NIH HHS AI171858, AI118426
6 · The paper itself

Abstract

Host immune responses are required for the efficient control of cryptosporidiosis. Immunity against

Indexed as

Cryptosporidiumdendritic cellsimmune responseinnate immunityintestinal parasite

Identifiers

PMID37110479
PMCPMC10144555
OpenAlexW4366278972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.